Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Rheumatology Reports

• Publication date

  2013-06-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11926-013-0343-1PMID 23754504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review.

  2013cited by this paper
• Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.

  2012cited by this paper
• Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.

  2012cited by this paper
• Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

  2012cited by this paper
• International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.

  2012cited by this paper
• IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality.

  2012cited by this paper
• Association of IgA Anti-ß2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus

  2011cited by this paper
• Auto-anticorpos anti-β2-glicoproteína I e síndrome metabólica

  2011cited by this paper
• Anti-beta2-glycoprotein I autoantibodies and metabolic syndrome.

  2011cited by this paper
• ‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

  2011cited by this paper
• ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

  2011cited by this paper
• Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study.

  2011cited by this paper
• IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus

  2010cited by this paper
• Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients

  2009cited by this paper
• Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

  2009cited by this paper
• IgA Anticardiolipin in Patients with Gastroenteric Tumor

  2009cited by this paper
• IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases

  2008cited by this paper
• IgA antiphospholipid antibodies are an independent risk factor for thromboses

  2008cited by this paper
• High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis.

  2008cited by this paper
• Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

  2006cited by this paper
• Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.

  2006cited by this paper
• Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.

  2006cited by this paper
• IgA antibodies to beta2-glycoprotein I and atherosclerosis.

  2006cited by this paper
• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  2006cited by this paper
• Ethnic and geographical variation in antiphospholipid (Hughes) syndrome

  2005cited by this paper
• Livedo reticularis ulcerado em paciente com anticorpo anticardiolipina tipo IgA

  2005cited by this paper
• Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.

  2005cited by this paper
• High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis

  2003cited by this paper
• Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity

  2003cited by this paper
• Elevated IgA and IgM Anticardiolipin Antibodies in Acute Kawasaki Disease

  2002cited by this paper
• Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.

  2001cited by this paper
• Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.

  2001cited by this paper
• The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

  2001cited by this paper
• Anti-cardiolipin and anti-beta 2 glycoprotein Iantibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures

  2001cited by this paper
• Anticardiolipin antibodies in Behçet's disease: a reassessment.

  2001cited by this paper
• Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus

  2000cited by this paper
• Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I

  2000cited by this paper
• Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis.

  2000cited by this paper
• Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.

  2000cited by this paper
• Increased transforming growth factor‐beta (TGF‐β)‐secreting T cells and IgA anti‐cardiolipin antibody levels during acute stage of childhood Henoch–Schönlein purpura

  2000cited by this paper
• Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus : Prevalence and clinical associations

  1999cited by this paper
• Isotype distribution and clinical relevance of anti‐β2‐glycoprotein I (β2‐GPI) antibodies: importance of IgA isotype

  1999cited by this paper
• IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus.

  1999cited by this paper
• A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.

  1999cited by this paper
• IgA-class anti-beta2-glycoprotein I in women with unexplained recurrent spontaneous abortion.

  1999cited by this paper
• Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and aβ2 glycoprotein-I is the most frequent isotype

  1999cited by this paper
• Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.

  1999cited by this paper
• Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus

  1999cited by this paper
• Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

  1999cited by this paper
• Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients.

  1999cited by this paper
• Catastrophic antiphospholipid syndrome associated with anti-beta-2-glycoprotein I IgA.

  1999cited by this paper
• IgA Anticardiolipin Antibodies – Relation with other Antiphospholipid Antibodies and Clinical Significance

  1998cited by this paper
• High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.

  1998cited by this paper
• Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis.

  1998cited by this paper
• Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.

  1997cited by this paper
• IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis.

  1996cited by this paper
• Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.

  1996cited by this paper
• Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

  1996cited by this paper
• The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

  1996cited by this paper
• Induction of Thrombosis in a Mouse Model by IgG, IgM and IgA Immunoglobulins from Patients with the Antiphospholipid Syndrome

  1995cited by this paper
• IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis

  1995cited by this paper
• Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.

  1995cited by this paper
• Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders

  1992cited by this paper
• Anticardiolipin antibodies in uveitis.

  1992cited by this paper
• Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion.

  1992cited by this paper
• Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.

  1991cited by this paper
• Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

  1989cited by this paper
• Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus.

  1988cited by this paper
• Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.

  1988cited by this paper
• Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

  1987cited by this paper

• Ischemic stroke in anti-β2-glycoprotein I IgA-associated non-criteria antiphospholipid syndrome: a case report of arterial recanalization via antiplatelet therapy

  2025cites this paper
• Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.

  2025cites this paper
• Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis.

  2024cites this paper
• Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients.

  2024cites this paper
• From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children

  2023cites this paper
• Preconception Non-criteria Antiphospholipid Antibodies and Risk of Subsequent Early Pregnancy Loss: a Retrospective Study

  2023cites this paper
• Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

  2023cites this paper
• Contribution of anti-β2 glycoprotein1 IgA testing in the diagnosis of seronegative-APS for patients with cerebral thrombosis

  2023cites this paper
• COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study.

  2022cites this paper
• Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study

  2022cites this paper
• Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters

  2022cites this paper
• Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One

  2021cites this paper
• Anti‐vimentin/cardiolipin IgA in the anti‐phospholipid syndrome: A new tool for ‘seronegative’ diagnosis

  2021cites this paper
• Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit

  2021cites this paper
• Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

  2021cites this paper
• Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries

  2021cites this paper
• Antibodies and diagnostic tests in antiphosholipid syndrome

  2021cites this paper
• Brief Report: Anti-phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID-19).

  2020cites this paper
• Antinuclear and antiphospholipid antibodies versus disease manifestations and clinical outcomes in systemic lupus erythematosus

  2020cites this paper
• [Seronegative antiphospholipid syndrome: Myth or reality?]

  2020cites this paper
• Antiphospholipid Syndrome.

  2020cites this paper
• The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome

  2020cites this paper
• Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

  2020cites this paper
• Vascular Thrombosis in COVID-19: A Potential Association with Antiphospholipid Antibodies. A Rapid Systematic Review

  2020cites this paper
• Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population

  2020cites this paper
• High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients

  2020cites this paper
• Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

  2020cites this paper
• The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS

  2020cites this paper
• Anti‐phospholipid antibodies and reproductive failures

  2020cites this paper
• Renal microvascular lesions in lupus nephritis

  2019cites this paper
• Antiphospholipid Syndrome

  2019cites this paper
• The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

  2019cites this paper
• Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual

  2018cites this paper
• Near-complete recanalization of jugular vein and multiple dural sinus thromboses with warfarin in a case of antiphospholipid syndrome

  2018cites this paper
• The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository

  2018cites this paper
• Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements

  2018cites this paper
• IgA anti-β2 glycoprotein I antibodies: Experience from a large center.

  2018cites this paper
• Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances

  2017cites this paper
• Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis

  2017cites this paper
• The Prevalence and Clinical Significance of Iga Anti-Phosphatidylserine/Prothrombin Antibodies in Systemic Autoimmune Diseases

  2017cites this paper
• The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome

  2017cites this paper
• Antiphospholipid Syndrome

  2017cites this paper
• Live Birth Pregnancy Outcome after First In Vitro Fertilization Treatment in a Patient with Systemic Lupus Erythematosus and Isolated High Positive IgA Anti-β2glycoprotein I Antibodies: A Case Report

  2017cites this paper
• β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome

  2017cites this paper
• Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies

  2017cites this paper
• Laboratory Diagnostics of Antiphospholipid Syndrome

  2017cites this paper
• Antiphospholipid syndrome.

  2016cites this paper
• APS - Diagnostics and challenges for the future.

  2016cites this paper
• Antibodies and Diagnostic Tests in Antiphospholipid Syndrome

  2016cites this paper
• Autoantibodies in SLE: Specificities, Isotypes and Receptors

  2016cites this paper
• Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome

  2016cites this paper
• Evaluation of three fully automated immunoassay systems for detection of IgA anti‐beta 2‐glycoprotein I antibodies

  2016cites this paper
• Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review.

  2015cites this paper
• Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China

  2015cites this paper
• Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies.

  2015cites this paper
• IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome.

  2014cites this paper
• IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome

  2014cites this paper
• Diverse vascular lesions in systemic lupus erythematosus and clinical implications

  2014cites this paper
• Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease

  2014cites this paper
• Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome

  2014cites this paper